中国阿尔茨海默病报告2024

China Alzheimer Report 2024

随着我国经济的持续增长和社会人口结构的显著变化,老龄化社会所带来的老年性疾病问题愈发受到关注,尤其是以阿尔茨海默病(Alzheimer’s disease,AD)为代表的神经退行性疾病,已成为严重影响老年人群健康和生活质量的重大挑战。近年来,中国的AD发病率、患病率和死亡率均呈现上升趋势,对患者家庭、社会乃至整个医疗保健系统构成了沉重的经济负担。为了积极应对这一挑战,响应国家“健康中国行动”的号召,推动医疗模式从疾病治疗向健康维护转变,由上海交通大学医学院附属仁济医院牵头,组织中国疾病预防控制中心慢性非传染性疾病预防控制中心、复旦大学公共卫生学院、上海市精神卫生中心、上海交通大学医学院附属瑞金医院、福建医科大学等多家权威机构的专家学者,共同编撰了《中国阿尔茨海默病报告2024》。该报告在2021、2022、2023年系列版本的基础上,进一步更新了中国AD的流行病学数据,深入分析了疾病经济负担的最新情况,并全面评估了我国AD诊疗服务的现状和公共卫生资源的配置。《中国阿尔茨海默病报告2024》的发布,不仅体现了我国在AD研究和防控方面的进步和努力,也彰显了全社会对老年健康问题的高度重视。本报告将为AD的预防、诊断和治疗提供科学的技术指导和有力的数据支持,为政府和相关部门制定针对性的卫生政策和干预措施提供专业依据,同时也为促进国内外在该领域的学术交流与合作搭建平台。期待通过这份报告的传播和应用,不仅能为专业人员提供参考和借鉴,也可以进一步提高公众对AD的认识,促进社会各界共同推动我国老年健康事业的发展,为实现“健康老龄化”而持续赋能。

With the sustained growth of economy and significant changes in social demographics,the issue of elderly-related diseases has increasingly drawn attention particularly.Alzheimer's disease(AD),as a representative disease of neurodegenerative diseases has become a major challenge,affecting the health and quality of life among the elderly population severely.In recent years,the incidence,prevalence,and mortality rate of AD increase in China,imposing substantial economic burdens on families,society,and the entire healthcare system.To proactively address this challenge and respond to the national'Healthy China Action'initiative,leading experts from Renji Hospital,Shanghai Jiao Tong University School of Medicine,and Chinese Center for Disease Control and Prevention Chronic Non-communicable Disease Control Center,Fudan University School of Public Health,Shanghai Mental Health Center,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Fujian Medical University,and other authoritative institutions,have jointly authored the'China Alzheimer Disease Report 2024'.Building upon previous editions of 2021,2022,and 2023,this report updates epidemiological data on AD in China,thoroughly analyzes the latest economic burdens of the disease,and comprehensively evaluates the current status of AD diagnosis and treatment services,as well as the allocation of public health resources in our country.The release of the'China Alzheimer Disease Report 2024'not only reflects China's progress and efforts in AD research and prevention,but also underscores the social heightened concern for elderly health issues.It aims to provide scientific and technical guidance and robust data support for the prevention,diagnosis,and treatment of AD,offering a professional basis for the government and relevant departments to formulate targeted health policies and intervention measures.Furthermore,it serves as a platform for promoting academic exchanges and cooperation in this field domestically and internationally.Through the dissemination and application of this report,we anticipate it will not only serve as a reference for professionals but also enhance public awareness of AD,promote active participation across various sectors of society,and jointly advance the development of elderly health care in China,empowering us towards achieving'healthy aging'.